Well,
from my limited knowledge, it was
1) raw material cornering, shortage, whatever...
2) generic industry very competitive, and they are just sick and tired of watching name brand companies set their high prices and they
stick, they are now doing the same.. remember... these are not ALL generic prices, just a picking of some.. In Mylans case, 7 drugs...
Besides Mylan, I have witnessed price increases (over 25%) on
- Purepak
- Geneva Generics
- Rugby
so I think we will more and more of this... the play would be to invest in drug wholesalers (cardinal, mckesson, etc...) and the individual stocks...
One IPO I bought into 2 months back was Schein.. they opened at 21 and have hit 32... that is my next buy...
I am holding Mylan October 35 calls now that I bought for $ 2.00..
Druggist
hope this helps !! |
